A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression

The International Journal of Neuropsychopharmacology
María ReinaresEduard Vieta

Abstract

Despite the high morbidity and mortality associated with bipolar depression, the optimal treatment for this phase is still a matter of debate. The aim of the current review was to provide updated evidence about the efficacy and tolerability of anticonvulsants in the treatment of acute bipolar depression. A comprehensive review of randomized controlled trials (RCTs) evaluating the use of anticonvulsants for the treatment of acute bipolar depression up to June 2011 was conducted by means of the PubMed-Medline database. Eligibility criteria included active comparator-controlled or placebo-controlled randomized studies involving monotherapy or combination therapy. A total of 18 RCTs fulfilled the inclusion criteria. Studies supported the efficacy of divalproex as monotherapy in acute bipolar depression but small sample size was a common methodological limitation. Findings were inconclusive for lamotrigine and carbamazepine although overall lamotrigine may have a beneficial but modest effect. Negative results were found for levetiracetam and gabapentin but the evidence base on these agents is scant. All anticonvulsants were generally well tolerated. No double-blind RCTs were found for the use of other anticonvulsants such as oxcarba...Continue Reading

References

Jan 1, 1986·The American Journal of Psychiatry·R M PostR T Joffe
Jul 1, 1980·The American Journal of Psychiatry·J C Ballenger, R M Post
Jun 24, 1999·Cellular and Molecular Neurobiology·T A KetterR M Post
May 24, 2000·Acta Psychiatrica Scandinavica·G M MacQueenR T Joffe
Dec 6, 2000·Journal of Clinical Psychopharmacology·M A FryeR M Post
Jun 5, 2002·Archives of General Psychiatry·Lewis L JuddMartin B Keller
Jun 5, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Laszlo GyulaiPatricia J Wozniak
Nov 12, 2003·Archives of General Psychiatry·Mauricio TohenAlan Breier
Nov 25, 2003·The Journal of Clinical Psychiatry·Joseph R CalabreseUNKNOWN Lamictal 605 Study Group
Mar 23, 2005·Journal of Affective Disorders·Lori L DavisFrederick Petty
Jan 27, 2006·The Cochrane Database of Systematic Reviews·Kamini VasudevAllan Young
Feb 8, 2006·Life Sciences·Benício N FreyFlávio Kapczinski
Dec 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Mauricio TohenHeinz Grunze
Mar 17, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Eduard Vieta, Adriane R Rosa
Apr 28, 2007·Neuroscience and Biobehavioral Reviews·Michel Bourin, Corina Prica
Aug 30, 2008·The International Journal of Neuropsychopharmacology·Konstantinos N Fountoulakis, Eduard Vieta
Jan 2, 2009·The British Journal of Psychiatry : the Journal of Mental Science·John R GeddesGuy M Goodwin
Feb 10, 2009·The Journal of Clinical Psychiatry·Marc L M van der LoosUNKNOWN LamLit Study Group
Mar 31, 2009·Journal of Psychopharmacology·G M Goodwin, UNKNOWN Consensus Group of the British Association for Psychopharmacology
Apr 16, 2009·Acta Psychiatrica Scandinavica. Supplementum·G S MalhiUNKNOWN CADE Clinic, University of Sydney
Nov 11, 2009·Current Opinion in Psychiatry·Konstantinos N Fountoulakis
Nov 21, 2009·Journal of Affective Disorders·L A SmithC L Bowden
Feb 13, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeUNKNOWN WFSBP Task Force On Treatment Guidelines For Bipolar Disorders
Apr 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Ryan J Van Lieshout, Glenda M MacQueen
Apr 27, 2010·Harvard Review of Psychiatry·Ross J BaldessariniCharles L Bowden
Jun 12, 2010·Journal of Affective Disorders·Alessandra M A NivoliEduard Vieta
Jul 30, 2010·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Adriane R RosaEduard Vieta
Aug 3, 2010·The Journal of Clinical Psychiatry·Michael J GitlinLori L Altshuler
Sep 4, 2010·Journal of Clinical Psychopharmacology·Eduard VietaBjörn Paulsson

❮ Previous
Next ❯

Citations

Jul 9, 2014·Journal of Neurosciences in Rural Practice·Ather Muneer
Sep 15, 2014·Psychiatry Research·Li-Rong TangChuan-Yue Wang
May 2, 2014·Expert Review of Neurotherapeutics·Cecilio AlamoPilar García-García
Jan 25, 2016·Revista de psiquiatrí́a y salud mental·Javier Salvador SánchezMaría Mur Laín
Dec 31, 2014·International Journal of Psychiatry in Clinical Practice·Konstantinos N FountoulakisSiegfried Kasper
Dec 9, 2015·The Australian and New Zealand Journal of Psychiatry·Gin S MalhiAjeet B Singh
May 7, 2015·The Australian and New Zealand Journal of Psychiatry·María ReinaresEduard Vieta
Apr 11, 2018·Evidence-based Mental Health·Antonio PretiKonstantinos N Fountoulakis
Jun 19, 2015·Current Psychiatry Reports·Andrea MurruEduard Vieta
Sep 5, 2014·Harvard Review of Psychiatry·Othman Mohammad, David N Osser
Jun 8, 2015·Journal of Clinical Psychopharmacology·Steven L DubovskyJordan C Serotte
May 12, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Erika Tovar-GudiñoMario Fernández-Zertuche
Jan 7, 2020·International Journal of Bipolar Disorders·Ross J BaldessariniLeonardo Tondo
Feb 13, 2020·Focus : Journal of Life Long Learning in Psychiatry
Nov 18, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Josué Rodríguez-LozadaMario Fernández-Zertuche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.